BIOMAT Database Logo BIOMAT Database Logo

[Mechanisms of cellular action of anti-arrhythmia agents]. 1978

C Sebag, and G Motté

UI MeSH Term Description Entries
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D006329 Heart Conduction System An impulse-conducting system composed of modified cardiac muscle, having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart. Conduction System, Heart,Conduction Systems, Heart,Heart Conduction Systems,System, Heart Conduction,Systems, Heart Conduction
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic

Related Publications

C Sebag, and G Motté
[Cellular mechanisms of the action of anti-arrhythmia agents].
January 1978, Kardiologia polska,
C Sebag, and G Motté
[Mechanisms of cellular action of anti-arrhythmia drugs].
January 1987, Archives des maladies du coeur et des vaisseaux,
C Sebag, and G Motté
[Mechanisms of action of class III anti-arrhythmia agents].
January 1995, Archives des maladies du coeur et des vaisseaux,
C Sebag, and G Motté
[Combined action of anti-arrhythmia agents].
June 1991, Biulleten' eksperimental'noi biologii i meditsiny,
C Sebag, and G Motté
[Action of anti-arrhythmia agents on intracardiac conduction].
January 1974, Acta cardiologica,
C Sebag, and G Motté
[Anti-arrhythmia agents: classification, mechanisms of action, principles of drug choice in clinical practice].
January 1993, Kardiologiia,
C Sebag, and G Motté
[Classification of anti-arrhythmia drugs and their mechanism of action. Iatrogeny of anti-arrhythmia agents].
April 1992, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology,
C Sebag, and G Motté
[Action of anti-arrhythmia agents in ischemia and hyperoxia].
January 1988, Farmakologiia i toksikologiia,
C Sebag, and G Motté
Action mechanisms of anti-invasive agents.
January 1986, Anticancer research,
C Sebag, and G Motté
[Electrophysiological mechanisms of the anti-arrhythmia action of ethacizin].
January 1986, Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR,
Copied contents to your clipboard!